- Home
- ALVO vs MLKN Comparison
ALVO vs MLKN Comparison
Compare ALVO & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | MLKN |
|---|---|---|
| Founded | 2013 | 1905 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | ALVO | MLKN |
|---|---|---|
| Price | $4.17 | $16.24 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 721.1K | 653.3K |
| Earning Date | 05-06-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | N/A | ★ $3,669,900,000.00 |
| Revenue This Year | $13.28 | $5.94 |
| Revenue Next Year | $18.63 | $3.78 |
| P/E Ratio | $18.20 | ★ $15.91 |
| Revenue Growth | N/A | ★ 1.14 |
| 52 Week Low | $2.94 | $13.77 |
| 52 Week High | $9.94 | $23.18 |
Technical Indicators
Market Signals| Indicator | ALVO | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 57.59 |
| Support Level | $3.09 | $13.87 |
| Resistance Level | $5.46 | $16.41 |
| Average True Range (ATR) | 0.28 | 0.58 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 76.06 | 85.41 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.